The mitochondrial ribosome of the protozoan Acanthamoeba castellanii is the target for macrolide antibiotics

Molecular and Biochemical Parasitology

Volumn 135, Issue 2, 2004, Pages 225-229

  Mathis, Alexander ^a   Wild, Peter ^a   Deplazes, Peter ^a   Boettger, Erik C ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Acanthamoeba; Drug resistance; Macrolide; Mitochondria; Protein synthesis inhibitors; Ribosomal RNA

Indexed keywords

MACROLIDE; CLARITHROMYCIN; GENTAMICIN; HYGROMYCIN B;

ACANTHAMOEBA CASTELLANII; ANTIPROTOZOAL ACTIVITY; ARTICLE; BRAIN INFECTION; CONTROLLED STUDY; DRUG TARGETING; EYE INFECTION; MITOCHONDRION; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RIBOSOME; RNA SEQUENCE; SKIN INFECTION; ACANTHAMOEBA; ANIMAL; DRUG EFFECT; ELECTRON MICROSCOPY; ULTRASTRUCTURE;

ACANTHAMOEBA; ACANTHAMOEBA CASTELLANII; PROTOZOA;

ACANTHAMOEBA; ANIMALS; CLARITHROMYCIN; GENTAMICINS; HYGROMYCIN B; MACROLIDES; MICROSCOPY, ELECTRON; MITOCHONDRIA; RIBOSOMES;

EID: 1942446017     PISSN: 01666851     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molbiopara.2004.02.004     Document Type: Article

References (39)

1. Araujo F.G., Guptill D.R., Remington J.S. Azithromycin, a macrolide antibiotic with potent activity against Toxoplasma gondii. Antimicrob Agents Chemother. 32:1988;755-757.
2. Edlind T.D. Susceptibility of Giardia lamblia to aminoglycoside protein synthesis inhibitors: correlation with rRNA structure. Antimicrob Agents Chemother. 33:1989;484-488.
3. Sadiq S.T., Glasgow K.W., Drakeley C.J.et al. Effects of azithromycin on malariometric indices in The Gambia. Lancet. 346:1995;881-882.
4. Griffiths J.K., Balakrishnan R., Widmer G., Tzipori S. Paromomycin and geneticin inhibit intracellular Cryptosporidium parvum without trafficking through the host cell cytoplasm: implications for drug delivery. Infect. Immun. 66:1998;3874-3883.
5. McConkey G.A., Rogers M.J., McCutchan T.F. Inhibition of Plasmodium falciparum protein synthesis. Targeting the plastid-like organelle with thiostrepton. J. Biol. Chem. 272:1997;2046-2049.
6. Rogers M.J., Cundliffe E., McCutchan T.F. The antibiotic micrococcin is a potent inhibitor of growth and protein synthesis in the malaria parasite. Antimicrob Agents Chemother. 42:1998;715-716.
7. Uip D.E., Lima A.L., Amato V.S., Boulos M., Neto V.A., Bem David D. Roxithromycin treatment for diarrhoea caused by Cryptosporidium spp. in patients with AIDS. J. Antimicrob. Chemother. 41:1998;93-97.
8. Pukrittayakamee S., Clemens R., Chantra A.et al. Therapeutic responses to antibacterial drugs in vivax malaria. Trans. R. Soc. Trop. Med. Hyg. 95:2001;524-528.
9. Derouin F. Anti-toxoplasmosis drugs. Curr. Opin. Invest. Drugs. 2:2001;1368-1374.
10. Krolewiecki A., Leon S., Scott P., Abraham D. Activity of azithromycin against Leishmania major in vitro and in vivo. Am. J. Trop Med. Hyg. 67:2002;273-277.
11. Beckers C.J., Roos D.S., Donald R.G.et al. Inhibition of cytoplasmic and organellar protein synthesis in Toxoplasma gondii. Implications for the target of macrolide antibiotics. J. Clin. Invest. 95:1995;367-376.
12. Fichera M.E., Roos D.S. A plastid organelle as a drug target in apicomplexan parasites. Nature. 390:1997;407-409.
13. Clough B., Strath M., Preiser P., Denny P., Wilson I.R. Thiostrepton binds to malarial plastid rRNA. FEBS Lett. 406:1997;123-125.
14. McFadden G.I., Roos D.S. Apicomplexan plastids as drug targets. Trends Microbiol. 7:1999;328-333.
15. Roos D.S. The apicoplast as a potential therapeutic target in Toxoplasma and other apicomplexan parasites: some additional thoughts. Parasitol Today. 15:1999;41.
16. Camps M., Arrizabalaga G., Boothroyd J. An rRNA mutation identifies the apicoplast as the target for clindamycin in Toxoplasma gondii. Mol. Microbiol. 43:2002;1309-1318.
17. Ginsburg H., Divo A.A., Geary T.G., Boland M.T., Jensen J.B. Effects of mitochondrial inhibitors on intraerythrocytic Plasmodium falciparum in in vitro cultures. J. Protozool. 33:1986;121-125.
18. Kiatfuengfoo R., Suthiphongchai T., Prapunwattana P., Yuthavong Y. Mitochondria as the site of action of tetracycline on Plasmodium falciparum. Mol. Biochem. Parasitol. 34:1989;109-115.
19. Lin Q., Katakura K., Suzuki M. Inhibition of mitochondrial and plastid activity of Plasmodium falciparum by minocycline. FEBS Lett. 515:2002;71-74.
20. De Stasio E.A., Moazed D., Noller H.F., Dahlberg A.E. Mutations in 16S ribosomal RNA disrupt antibiotic-RNA interactions. EMBO J. 8:1989;1213-1216.
21. Douthwaite S., Aagaard C. Erythromycin binding is reduced in ribosomes with conformational alterations in the 23S rRNA peptidyl transferase loop. J. Mol. Biol. 232:1993;725-731.
22. Harris E.H., Burkhart B.D., Gillham N.W., Boynton J.E. Antibiotic resistance mutations in the chloroplast 16S and 23S rRNA genes of Chlamydomonas reinhardtii: correlation of genetic and physical maps of the chloroplast genome. Genetics. 123:1989;281-292.
23. Prammananan T., Sander P., Brown B.A.et al. A single 16S ribosomal RNA substitution is responsible for resistance to amikacin and other 2-deoxystreptamine aminoglycosides in Mycobacterium abscessus and Mycobacterium chelonae. J. Infect. Dis. 177:1998;1573-1581.
24. Sander P., Prammananan T., Meier A., Frischkorn K., Bottger E.C. The role of ribosomal RNAs in macrolide resistance. Mol. Microbiol. 26:1997;469-480.
25. Sander P., Prammananan T., Bottger E.C. Introducing mutations into a chromosomal rRNA gene using a genetically modified eubacterial host with a single rRNA operon. Mol. Microbiol. 22:1996;841-848.
26. Wang G., Taylor D.E. Site-specific mutations in the 23S rRNA gene of Helicobacter pylori confer two types of resistance to macrolide-lincosamide- streptogramin B antibiotics. Antimicrob Agents Chemother. 42:1998;1952-1958.
27. Bottger E.C., Springer B., Prammananan T., Kidan Y., Sander P. Structural basis for selectivity and toxicity of ribosomal antibiotics. EMBO Rep. 2:2001;318-323.
28. Rodriguez-Fonseca C., Amils R., Garrett R.A. Fine structure of the peptidyl transferase centre on 23S-like rRNAs deduced from chemical probin of antibiotic-ribosome complexes. J. Mol. Biol. 247:1995;224-235.
29. Pfister P., Risch M., Brodersen D.E., Bottger E.C. Role of 16S rRNA helix 44 in ribosomal resistance to hygromycin B. Antimicrob Agents Chemother. 47:2003;1496-1502.
30. Marciano-Cabral F., Cabral G. Acanthamoeba spp. as agents of disease in humans. Clin. Microbiol. Rev. 16:2003;273-307.
31. Cole J.R., Chai B., Marsh T.L.et al. Garrity GM and others. The Ribosomal Database Project (RDP-II): previewing a new autoaligner that allows regular updates and the new prokaryotic taxonomy. Nucleic Acids Res. 31:2003;442-443.
32. Hall T.A. BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucleic Acids Symp Ser. 41:1999;95-98.
33. Byers T.J. Growth, reproduction, and differentiation in Acanthamoeba. Int. Rev. Cytol. 61:1979;283-338.
34. Akins R.A., Byers T.J. Differentiation promoting factors induced in Acanthamoeba by inhibitors of mitochondrial macromolecule synthesis. Dev. Biol. 78:1980;126-140.
35. Prammananan T., Sander P., Springer B., Bottger E.C. RecA-mediated gene conversion and aminoglycoside resistance in strains heterozygous for rRNA. Antimicrob Agents Chemother. 43:1999;447-453.
36. Goldenberger D., Kunzli A., Vogt P., Zbinden R., Altwegg M. Molecular diagnosis of bacterial endocarditis by broad-range PCR amplification and direct sequencing. J. Clin. Microbiol. 35:1997;2733-2739.
37. Bowers B., Korn E.D. The fine structure of Acanthamoeba castellanii (Neff strain). II. Encystment. J. Cell Biol. 41:1969;786-805.
38. Wild P., Gabrieli A., Schraner E.M.et al. Reevaluation of the effect of lysoyzme on Escherichia coli employing ultrarapid freezing followed by cryoelectronmicroscopy or freeze substitution. Microsc Res. Tech. 39:1997;297-304.
39. Wild P., Schraner E., Adler H., Humbel B. Enhanced resolution of membranes in cultured cells by cryoimmobilization and freeze-substitution. Microsc Res. Tech. 53:2001;313-321.